Following COVID Win, Island Biotech Targets Monkeypox
Outside the pox: After revolutionizing COVID testing, Applied DNA Sciences is getting out in front of the monkeypox virus.
By GREGORY ZELLER //
Applied DNA Sciences is ready to play a little monkey ball.
The Stony Brook-based biotech – part supply-chain authenticator, part Polymerase Chain Reaction-based DNA technology leader, all innovation – is seeking New York State Department of Health approvals for its first monkeypox virus test.
Specifically, Applied DNA Clinical Labs – a wholly owned LLC launched in 2020 to flesh out the parent’s virology and oncology testing capabilities – has applied for the state validation package. It would be the spinoff’s second successful laboratory developed test this year, following NYS Health Department approvals in January for Applied DNA Clinical Labs’ next-generation COVID detector.
